Homocysteine may involve in the pathogenesis of Behcet's disease by inducing inflammation

Mediators of Inflammation

Volumn 2008, Issue , 2008, Pages

  Kartal Durmazlar, Selda Pelin ^a   Akgul, Ahmet ^b   Eskioglu, Fatma ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PARAMETER; PATHOGENESIS; PRIORITY JOURNAL; BLOOD; PHYSIOLOGY;

ADULT; BEHCET SYNDROME; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HOMOCYSTEINE; HUMANS; INFLAMMATION; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59549091793     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2008/407972     Document Type: Article

References (44)

1. McCully K. S., Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis American Journal of Pathology 1969 56 1 111 128
2. Harker L. A., Slichter S. J., Scott C. R., Ross R., Homocystinemia. Vascular injury and arterial thrombosis The New England Journal of Medicine 1974 291 11 537 543
3. Harker L. A., Harlan J. M., Ross R., Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons Circulation Research 1983 53 6 731 739
4. Hansrani M., Gillespie J. I., Stansby G., Homocysteine in myointimal hyperplasia European Journal of Vascular and Endovascular Surgery 2002 23 1 3 10
5. Den Heijer M., Rosendaal F. R., Blom H. J., Gerrits W. B. J., Bos G. M. J., Hyperhomocysteinemia and venous thrombosis: a meta-analysis Thrombosis and Haemostasis 1998 80 6 874 877
6. Ray J. G., Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease Archives of Internal Medicine 1998 158 19 2101 2106
7. Wald D. S., Law M., Morris J. K., Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis British Medical Journal 2002 325 7374 1202 1206
8. Clarke R., Collins R., Lewington S., Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis The Journal of the American Medical Association 2002 288 16 2015 2022
9. Durand P., Prost M., Loreau N., Lussier-Cacan S., Blache D., Impaired homocysteine metabolism and atherothrombotic disease Laboratory Investigation 2001 81 5 645 672
10. Hankey G. J., Eikelboom J. W., Homocysteine and vascular disease The Lancet 1999 354 9176 407 413
11. Behcet H., Über rezidivierende, aphtöse, durch ein virus verursachte Geshwüre am Mund am Auge und an den Genitalien Dermatol Wochensch 1937 105 1152 1157
12. Koc Y., Güllü I., Akpek G., Vascular involvement in Behçet's disease Journal of Rheumatology 1992 19 3 402 410
13. Dudman N. P. B., Temple S. E., Guo X. W., Fu W., Perry M. A., Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo Circulation Research 1999 84 4 409 416
14. Aksu K., Turgan N., Oksel F., Hyperhomocysteinaemia in Behçet's disease Rheumatology 2001 40 6 687 690
15. Er H., Evereklioglu C., Cumurcu T., Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease British Journal of Ophthalmology 2002 86 6 653 657
16. Ateş A., Aydintuǧ O., Ölmez U., Düzgün N., Duman M., Serum homocysteine level is higher in Behçet's disease with vascular involvement Rheumatology International 2005 25 1 42 44
17. Sarican T., Ayabakan H., Turkmen S., Kalaslioglu V., Baran F., Yenice N., Homocysteine: an activity marker in Behçet's disease? Journal of Dermatological Science 2007 45 2 121 126
18. Özkan Y., Yardim-Akaydin S., Sepici A., Engin B., Sepici V., Şimşek B., Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease Clinical Chemistry and Laboratory Medicine 2007 45 1 73 77
19. Yesilova Z., Pay S., Oktenli C., Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy? Rheumatology International 2005 25 6 423 428
20. Ozdemir R., Barutcu I., Sezgin A. T., Vascular endothelial function and plasma homocysteine levels in Behçet's disease The American Journal of Cardiology 2004 94 4 522 525
21. Lee Y. J., Kang S. W., Yang J. I., Coagulation parameters and plasma total homocysteine levels in Behçet's disease Thrombosis Research 2002 106 1 19 24
22. Leiba M., Seligsohn U., Sidi Y., Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease Annals of the Rheumatic Diseases 2004 63 11 1445 1449
23. Selhub J., Jacques P. F., Wilson P. W., Rush D., Rosenberg I. H., Vitamin status and intake as primary determinants of homocysteinemia in an elderly population The Journal of the American Medical Association 1993 270 22 2693 2698
24. Evereklioglu C., Er H., Türköz Y., Çekmen M., Serum levels of TNF- α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease Mediators of Inflammation 2002 11 2 87 93
25. Wechsler B., Davatchi F., Mizushima Y., Criteria for diagnosis of Behçet's disease The Lancet 1990 335 8697 1078 1080
26. Bhakta B. B., Brennan P., James T. E., Chamberlain M. A., Noble B. A., Silman A. J., Behçet's disease: evaluation of a new instrument to measure clinical activity Rheumatology 1999 38 8 728 733
27. Lawton G., Bhakta B. B., Chamberlain M. A., Tennant A., The Behçet's disease activity index Rheumatology 2004 43 1 73 78
28. Korkmaz C., Bozan B., Kosar M., Sahin F., Gülbas Z., Is there an association of plasma homocysteine levels with vascular involvement in patients with Behçet's syndrome? Clinical and Experimental Rheumatology 2002 20 4, supplement 26 S30 S34
29. Mege J.-L., Dilsen N., Sanguedolce V., Over production of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects Journal of Rheumatology 1993 20 9 1544 1549
30. Evereklioglu C., Current concepts in the etiology and treatment of Behçet disease Survey of Ophthalmology 2005 50 4 297 350
31. Baggiolini M., Dewald B., Moser B., Human chemokines: an update Annual Review of Immunology 1997 15 675 705
32. Kobayashi M., Ito M., Nakagawa A., Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease Histopathology 2000 36 4 362 371
33. Haznedaroglu I. C., Ozdemir O., Ozcebe O., Dundar S. V., Kirazli S., Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease Thrombosis and Haemostasis 1996 75 6 974 975
34. Haznedaroglu I. C., Özcebe O. I., Özdemir O., Çelik I., Dündar S. V., Kirazli Ş., Impaired haemostatic kinetics and endothelial function in Behçet's disease Journal of Internal Medicine 1996 240 4 181 187
35. Ohkuma T., Minagawa T., Takada N., Ohno M., Oda H., Ohashi H., C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients American Journal of Kidney Diseases 2003 42 2 355 361
36. Bogdanski P., Pupek-Musialik D., Dytfeld J., Lacinski M., Jablecka A., Jakubowski H., Plasma homocysteine is a determinant of tissue necrosis factor- α in hypertensive patients Biomedicine and Pharmacotherapy 2008 62 6 360 365
37. Gori A. M., Corsi A. M., Fedi S., A proinflammatory state is associated with hyperhomocysteinemia in the elderly American Journal of Clinical Nutrition 2005 82 2 335 341
38. Widner B., Leblhuber F., Frick B., Laich A., Artner-Dworzak E., Fuchs D., Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease Journal of Neural Transmission 2002 109 12 1445 1452
39. Koga T., Claycombe K., Meydani M., Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells Atherosclerosis 2002 161 2 365 374
40. Li M., Chen J., Li Y.-S., Feng Y.-B., Gu X., Shi C.-Z., Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia International Journal of Cardiology 2006 106 2 285 288
41. Silverman M. D., Tumuluri R. J., Davis M., Lopez G., Rosenbaum J. T., Lelkes P. I., Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 4 587 592
42. Hofmann M. A., Lalla E., Lu Y., Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model The Journal of Clinical Investigation 2001 107 6 675 683
43. Sattar N., Crompton P., Cherry L., Kane D., Lowe G., McInnes I. B., Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study Arthritis and Rheumatism 2007 56 3 831 839
44. Ballow M., Nelson R., Immunopharmacology: immunomodulation and immunotherapy The Journal of the American Medical Association 1997 278 22 2008 2017